Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 6;33(2):147-160.
doi: 10.1515/revneuro-2021-0047. Print 2022 Feb 23.

Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1

Affiliations
Review

Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1

Kiarash Saleki et al. Rev Neurosci. .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is identified as the cause of coronavirus disease 2019 (COVID-19), and is often linked to extreme inflammatory responses by over activation of neutrophil extracellular traps (NETs), cytokine storm, and sepsis. These are robust causes for multi-organ damage. In particular, potential routes of SARS-CoV2 entry, such as angiotensin-converting enzyme 2 (ACE2), have been linked to central nervous system (CNS) involvement. CNS has been recognized as one of the most susceptible compartments to cytokine storm, which can be affected by neuropilin-1 (NRP-1). ACE2 is widely-recognized as a SARS-CoV2 entry pathway; However, NRP-1 has been recently introduced as a novel path of viral entry. Apoptosis of cells invaded by this virus involves Fas receptor-Fas ligand (FasL) signaling; moreover, Fas receptor may function as a controller of inflammation. Furthermore, NRP-1 may influence FasL and modulate cytokine profile. The neuroimmunological insult by SARS-CoV2 infection may be inhibited by therapeutic approaches targeting soluble Fas ligand (sFasL), cytokine storm elements, or related viral entry pathways. In the current review, we explain pivotal players behind the activation of cytokine storm that are associated with vast CNS injury. We also hypothesize that sFasL may affect neuroinflammatory processes and trigger the cytokine storm in COVID-19.

Keywords: COVID-19; central nervous system; coronavirus; cytokine storm; hyperinflammation; neuropilin-1.

PubMed Disclaimer

References

    1. Arbour, N., Day, R., Newcombe, J., and Talbot, P.J. (2000). Neuroinvasion by human respiratory coronaviruses. J. Virol. 74: 8913–8921, https://doi.org/10.1128/jvi.74.19.8913-8921.2000.
    1. Barnes, B.J., Adrover, J.M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J.M., Dassler-Plenker, J., Guerci, P., Huynh, C., Knight, J.S., et al.. (2020). Targeting potential drivers of COVID-19: neutrophil extracellular traps. J. Exp. Med. 217: e20200652, https://doi.org/10.1084/jem.20200652.
    1. Beazley-Long, N., Hua, J., Jehle, T., Hulse, R.P., Dersch, R., Lehrling, C., Bevan, H., Qiu, Y., Lagrèze, W.A., Wynick, D., et al.. (2013). VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am. J. Pathol. 183: 918–929, https://doi.org/10.1016/j.ajpath.2013.05.031.
    1. Bernal-Bello, D., Jaenes-Barrios, B., Morales-Ortega, A., Ruiz-Giardin, J.M., García-Bermúdez, V., Frutos-Pérez, B., Farfán-Sedano, A.I., de Ancos-Aracil, C., Bermejo, F., and García-Gil, M. (2020). Imatinib might constitute a treatment option for lung involvement in COVID-19. Autoimmun. Rev. 218: 108518.
    1. Blanco-Melo, D., Nilsson-Payant, B., Liu, W.-C., Møller, R., Panis, M., Sachs, D., and Albrecht, R. (2020). SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems. Cell. 181(5): 1036–1045, doi:10.1016/j.cell.2020.04.026. 32416070.

Publication types

LinkOut - more resources